Peyton Martin

5.2k total citations · 1 hit paper
17 papers, 4.1k citations indexed

About

Peyton Martin is a scholar working on Epidemiology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Peyton Martin has authored 17 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Peyton Martin's work include Sepsis Diagnosis and Treatment (6 papers), Neutropenia and Cancer Infections (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Peyton Martin is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), Neutropenia and Cancer Infections (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Peyton Martin collaborates with scholars based in United States, Colombia and Israel. Peyton Martin's co-authors include Klingemann Hg, Jill Hows, Daniel Weisdorf, Thomas Ed, P Beatty, Donna Przepiorka, Kristen Price, Cristina Gutiérrez, Charles L. Sprung and Mike Hernández and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and Journal of Pain and Symptom Management.

In The Last Decade

Peyton Martin

14 papers receiving 4.0k citations

Hit Papers

1994 Consensus Conference on Acute GVHD Grading. 1995 2026 2005 2015 1995 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peyton Martin United States 5 3.4k 1.3k 1.0k 789 534 17 4.1k
Daniel Weisdorf United States 12 4.0k 1.2× 1.6k 1.2× 1.1k 1.1× 931 1.2× 547 1.0× 21 4.7k
Teresa Lamparelli Italy 36 3.2k 0.9× 1.4k 1.0× 1.1k 1.1× 687 0.9× 530 1.0× 99 4.0k
Gary Schoch United States 31 3.2k 0.9× 979 0.7× 1.1k 1.1× 775 1.0× 1.0k 1.9× 63 4.9k
Cindy Ippoliti United States 31 2.9k 0.9× 1.3k 1.0× 1.2k 1.2× 719 0.9× 578 1.1× 81 4.4k
Rainer Schwerdtfeger Germany 43 4.3k 1.3× 1.3k 1.0× 1.4k 1.4× 1.2k 1.5× 860 1.6× 126 6.0k
Junya Kanda Japan 28 2.0k 0.6× 811 0.6× 793 0.8× 391 0.5× 426 0.8× 265 2.8k
Daniel Weisdorf United States 27 2.5k 0.7× 1.1k 0.8× 602 0.6× 773 1.0× 187 0.4× 52 3.2k
Hee‐Je Kim South Korea 26 2.0k 0.6× 717 0.5× 736 0.7× 601 0.8× 419 0.8× 271 3.0k
Sergio Giralt United States 21 3.0k 0.9× 719 0.5× 799 0.8× 1.0k 1.3× 240 0.4× 40 3.6k
Chang‐Ki Min South Korea 28 2.1k 0.6× 703 0.5× 883 0.9× 513 0.7× 246 0.5× 262 2.9k

Countries citing papers authored by Peyton Martin

Since Specialization
Citations

This map shows the geographic impact of Peyton Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peyton Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peyton Martin more than expected).

Fields of papers citing papers by Peyton Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peyton Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peyton Martin. The network helps show where Peyton Martin may publish in the future.

Co-authorship network of co-authors of Peyton Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Peyton Martin. A scholar is included among the top collaborators of Peyton Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peyton Martin. Peyton Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gallagher, Colleen M., et al.. (2025). Adolescents’ and Young Adults’ Perspectives on Decision-Making and the Emotional Experience of Having Advanced Cancer. Journal of Pain and Symptom Management. 70(6). 569–581.
2.
Nates, Joseph L., et al.. (2024). Long-Term Survival of Patients With Cancer, Sepsis, and Vasopressor Requirements Based on Lactate Levels. Critical Care Explorations. 6(4). e1070–e1070. 2 indexed citations
3.
Hernández, Mike, Peyton Martin, Cristina Gutiérrez, et al.. (2022). Outcomes and Predictors of 28-Day Mortality in Patients With Solid Tumors and Septic Shock Defined by Third International Consensus Definitions for Sepsis and Septic Shock Criteria. CHEST Journal. 162(5). 1063–1073. 20 indexed citations
4.
Hernández, Mike, Peyton Martin, Cristina Gutiérrez, et al.. (2022). Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria. Journal of the National Comprehensive Cancer Network. 20(1). 45–53. 25 indexed citations
5.
Christensen, Eric, et al.. (2021). Humanizing the intensive care unit experience in a comprehensive cancer center: A patient- and family-centered improvement study. Palliative & Supportive Care. 20(6). 794–800. 4 indexed citations
6.
Laserna, Andrés, Peyton Martin, Michele Guindani, et al.. (2021). Artificial hyperventilation normalizes haemodynamics and arterial oxygen content in hypoxic rats. Anaesthesiology Intensive Therapy. 53(3). 223–231. 1 indexed citations
7.
Gutiérrez, Cristina, et al.. (2021). 1418: EFFECTS OF RECENT USE OF CHECKPOINT INHIBITORS ON OUTCOMES OF CANCER PATIENTS WITH SEPTIC SHOCK. Critical Care Medicine. 50(1). 711–711. 1 indexed citations
8.
Martin, Peyton, et al.. (2020). 1209: Septic Shock by Sepsis-3 Criteria Is Associated With Higher Mortality in Cancer Patients. Critical Care Medicine. 49(1). 608–608. 1 indexed citations
9.
Martin, Peyton, et al.. (2019). 566: CHECKPOINT INHIBITORS AND POTENTIALLY FATAL IMMUNE-RELATED ADVERSE EVENTS: A CASE SERIES. Critical Care Medicine. 48(1). 264–264. 1 indexed citations
10.
Laserna, Andrés, et al.. (2019). 1670: NEUTROPENIC SEPTIC SHOCK OUTCOMES IN CANCER PATIENTS AND THE INFLUENCE OF COLONY-STIMULATING FACTOR. Critical Care Medicine. 48(1). 810–810. 1 indexed citations
11.
Martin, Peyton, et al.. (2018). 1561: HETEROGENEOUS SEPTIC SHOCK MORTALITY REPORT: A LIMITATION FOR RESEARCH AND CLINICAL DECISIONS. Critical Care Medicine. 47(1). 756–756.
12.
Laserna, Andrés, et al.. (2018). 340: INCREASED SOFA SCORE IN THROMBOCYTOPENIC SEPTIC SHOCK IS NOT ASSOCIATED WITH HIGHER MORTALITY. Critical Care Medicine. 47(1). 151–151. 1 indexed citations
13.
Laserna, Andrés, et al.. (2018). 1576: OUTCOME OF SEPTIC SHOCK IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS. Critical Care Medicine. 47(1). 763–763. 1 indexed citations
14.
Martin, Peyton, et al.. (2017). Prescribing Pattern of Anticancer Drugs in a MedicalOncology Department of a Tertiary Care TeachingHospital. Annals of Medical and Health Sciences Research. 4 indexed citations
16.
Cuesta, Martín, Emilia Gómez Hoyos, Peyton Martin, et al.. (2012). An initial dose of 7.5 mg Tolvaptan is safe and effective in the treatment of hyponatremia caused by SIADH. 15th International & 14th European Congress of Endocrinology. 29. 3 indexed citations
17.
Przepiorka, Donna, Daniel Weisdorf, Peyton Martin, et al.. (1995). 1994 Consensus Conference on Acute GVHD Grading.. PubMed. 15(6). 825–8. 3986 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026